The results of testing the model of Welte, which assess if economic evaluations can be transferred or not, indicate that applying this model influences the costs and effects estimates when transferring data from economic evaluations.

Transferring economic evaluations, moving data from one country to another, is however hindered by several factors. These factors cause different results across countries when performing economic evaluations in health care.

Using data from foreign studies can save time and money compared with conducting all studies in the decision country. Recently, Welte's model was tested in a study called 'The Transferability of Economic Evaluations. Testing the Model of Welte'.

A case study was applied in which the results of the "all studies prediction" using all foreign studies and the "Welte's model prediction" with transferred foreign studies using Welte's model were compared with a Dutch study.

The study was co-authored by Saskia Knies, André Ament, Silvia Evers and Hans Severens of Maastricht University.

Says Saskia Knies: "Our results showed that applying the model of Welte helps to identify which economic evaluations are transferable. This will make the transferability of economic evaluations across countries more transparent."

The article will be discussed in V a future issue of Value in Health, the official journal of the International Society for Pharmacoeconomics and outcomes Research.

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research and help health care leaders to make decisions that are solidly evidence-based. The journal is published bi-monthly and has a regular readership of over 4,000 clinicians, decision-makers, and researchers worldwide.

ISPOR is a nonprofit, international organization that strives to translate pharmacoeconomics and outcomes research into practice to ensure that society allocates scarce health care resources wisely, fairly, and efficiently.

Source
ISPOR